|
Flavay's™
strong antioxidant power is patented—as a scavenger
of the free radicals that play a major role in the degradation of collagen
and initiation, duration and breakdown of inflammation.
That means that your joints hurt less and your blood flows better...


Flavay is totally safe to use; a
100% non-toxic and naturalbut powerfully effectivenutritional
supplement. Flavay™ is a highly specialized, nutritional complex of pairs
and triples of a specific molecule called "flavan-3-ol," isolated
from natural extracts, that has been extensively tested and examined clinically
for biological antioxidant protection, collagen strengthening, tissue
rebuilding, and other health producing outcomes.
For more than 50 years this antioxidant complex, now known as Flavay,
has produced stunning health results across Europe. Flavay™ is totally
safe to use100% non-toxic and natural. The benefits of Flavay™ are
particularly compelling because they address so many diverse body tissues
and conditions. Below is an overview of Flavay's™ proven health benefits:
- Acts as a superior antioxidant by preventing and fighting the harmful
effects of rampaging free radicals in the body.
- Regenerates other antioxidants in the body after they have quenched
free radicals, thereby vastly extending their unique antioxidant powers
and helping the body to maintains its natural antioxidant balance.
- Helps to regulate nitric oxideone of the newest good-bad free
radicals to demand the scientific spotlightas it normalizes blood
circulation, helps coordinate activity between the brain and immune
system, modulates communication between brain cells and is thereby deeply
involved in concentration, learning and memory.
- Promotes heart health.
- Reduces platelet aggregation.
- Increases the strength and elasticity of blood vessels, protecting
against rupture, leakage and degeneration.
- Enhances the ability of collagen to repair itself.
- Inhibits swelling (edema) and inflammation.
- Accelerates recovery time from strenuous games and workouts.
- Relieves functional problems associated with varicose veins.
- Reduces the tendency toward diabetic retinopathy.
- Improves skin health by strengthening and rebuilding the body's collagen
proteins.
- Helps prevent the degradation of collagen and elastin, thereby helping
to enhance the elasticity of the skin and offset visible signs of premature
aging.
- Supports and protects the body during stressful times.
What is Flavay™?
Flavay is more than a single nutrient. It is a very specific, standardized
and isolated, singular polyphenol complex defined and perfected by Dr.
Jack Masquelier in France; validated by the French Ministry of Health
and documented by a library of research consisting of many patents and
hundreds of scientific papers, articles, doctorate theses, lectures and
presentations.
Flavay™ is not a simple bioflavonoid (this is important because
many are non-bioavailable or even toxic). Flavay™ is comprised of
pairs and triples of a specific molecule called, flavan-3-ol.
This highly defined, polyphenol complex is proven fully bioavailable,
safe and effective by numerous human studies, manufactured in France and
used worldwide since 1950.

"Radical Scavenger Effect"
of Flavay™
Protected by U.S. Patent No. 4,698,360
Patented and licensed in France for therapeutic uses, the U.S. Government
granted Dr. Masquelier a patent on October 6, 1987 which allows his proanthocyanidins
complex, now sold as Flavay™, to be used as an antioxidant here
in the United States. Flavay is the productused in the actual
experimentsby which Dr. Jack Masquelier established and patented
the "radical scavenger effect."
"[A] method for preventing and fighting the harmful biological
effects of free radicals in the organism of warm blooded animals
and more especially human beings, namely cerebral involution, hypoxia
following atherosclerosis, cardiac or cerebral infarction, tumour
promotion, inflammation, ischaemia, alterations of the synovial liquid,
collagen degradation, among others. The method consists in administering
to said animals and especially to human beings an amount, efficient
against said effects, of a plant extract with a proanthocyanidins
content which has a radical scavenger effect"Dr.
Jack Masquelier, U.S. Patent No. 4,698,360.
Method of Action
Considerable research has demonstrated that Flavay
has several key actions when consumed:
- Flavay™ is a powerfully
effective ANTIOXIDANT that recycles other antioxidants in the
body after they have quenched corrosive free radicals which
affect many tissues and conditions including cognitive
impairment and premature aging.
- Flavay™ helps to regulate
the good-bad free radical, NITRIC OXIDE, which is essential for:
normal blood circulation, coordinating activity between the
immune system and the brain, and modulating communication
between brain cells—and is thereby deeply involved in
concentration, learning and memory.
- Flavay™ inhibits the release
and synthesis of HISTAMINE, a key factor in the promotion of
INFLAMMATION; reactions associated with conditions like vascular
diseases, allergies, and arthritis.
- Flavay™ strengthens and
rebuilds COLLAGEN proteins, improving skin and blood vessel
health.
|
Free Radicals:
Both Foe and Friend
Contemporary scientific studies in neurology and immunology have demonstrated
that the body's own immune system has the ability to damage healthy cells.
When the body's immune system mobilizes, our cells produce by-products
called oxygen free radicals, like pellets of poison, that go
to work to destroy invaders by interfering with their cellular machinery,
literally dissolving or breaking down the genetic material of bacteria,
toxins, and viruses.
When all is going well, the immune system is capable of identifying foreign
invaders such as viruses and bacteria. If functioning properly, our immune
components do not turn against our own body's cells. Unfortunately, free
radicals can interfere with the biological components of our healthy cells
just as they destroy invaders, literally dismantling the body's essential
cellular proteins, fatty cell membranes and DNA.
The most important natural defenses we have against free radical damage
are our body's natural "antioxidants," a broad range of chemical
substances that all have one thing in common: they ward off free radical
damage to cells. However, in many neurological diseasesincluding
Parkinson's, Alzheimer's, chronic fatigue, and multiple sclerosisthe
brain's specialized antioxidant mechanisms fail. The cause of the failure
might be genetic, environmental, or even dietary, but the consequences
are the same: unchecked free radical activity on the brain.
The excessive production of one free radical in particular, nitric oxide,
can be blamed for throwing the brain-immune systems off kilter and causing
some of the brain's worst free radical damage. Over the past decade, scientists
have shown that the overproduction of nitric oxide through a combination
of immune and nervous system activity often sparked by an infection,
exposure to a toxin, or as part of the aging processplays a key
role in the development of neurological diseases.
Antioxidants:
Your Best Weapon Against Toxic Free Radicals
Antioxidants can neutralize free radical attacks and are especially important
as we age. During any challenge to your immune systembecause of
disease, infections, toxic exposure, stress or agingyou need extra
antioxidants to help scavenge the free radicals naturally produced by
the immune system's cells during warfare.
Until recently, scientists believed that each antioxidant worked separately
in the body, independently of the others. We now know that isn't true.
Current research demonstrates that key antioxidants and their co-factor
nutrients work synergistically with one another in the body. Antioxidants
work together in the bodynot alone.
Superior Antioxidant Support
Flavay™ is superior to other antioxidants because its protective effects
are multiplied in the body: while it provides its own, powerful antioxidant
protection, it also supports the dynamic interplay between other antioxidants
in the body. Flavay's™ ability to recycle, or regenerate vitamins
C and E after they have quenched free radicals vastly extends their unique
antioxidant powers, helping the body to maintain its synergistic antioxidant
balance.
Flavay™ is rapidly absorbed and very quickly distributed throughout
the body. As a free radical fighter, Flavay™ comes to the aid of
the body more quickly than other antioxidants, reducing the potential
for free radical damage and the ravages of aging. Flavay™ also possesses
more reactive sites for neutralizing free radicals than other known antioxidants.
Furthermore, Flavay™ permits reactivity with both positively and
negatively charged free radical species. What this means is that Flavay™
can quench or scavenge (neutralize) a broad variety
of free radicals. Highly reactive as an antioxidant in both lipid (fat)
and aqueous (water) phases, Flavay™ neutralizes oxygen free radicals
and is a valuable protector of healthy cells in a variety of internal
conditions. This is a unique property among antioxidants, as most work
either in lipid or aqueous phases, but not both. Research shows that Flavay™
can regulate nitric oxide and quench superoxide and the hydroxyl radical.
This is extremely important. Of all the free radicals formed in the body,
the hydroxyl radical is the most dangerous because it can directly attack
DNA. As a free radical scavenger, Flavay™ is like an antioxidant
prize fighter that can successfully take on all challengers, big or small,
in any kind of weather.
CLICK HERE TO SEE WHAT ACTUAL
CUSTOMERS ARE SAYING
Statements made herein have not been
evaluated by the Food and Drug Administration. These products are not intended
to diagnose, treat, cure or prevent any disease.
|
REFERENCES:
Top
|
Masquelier, J. Plant extract with a proanthocyanidins content
as a therapeutic agent having radical scavenging effect and use thereof.
U.S. Patent No. 4,698,360, 1987.
Masquelier, J. A lifetime devoted to OPC and Pycnogenols. Alfa Omega
Editrice,
Pub., 1996.
Schwitters, B., Masquelier, J. OPC in practice. Alfa Omega
Editrice, Publishers,
1995.
Kilham, C., Masquelier, J. OPC: The miracle antioxidant. Keats Publishing,
Inc., 1997.
Mindell, E., et al. Earl Mindells vitamin bible for the 21st century.
Warner Books, Inc., 1999.
Passwater, R.A. The antioxidants: the nutrients that guard your body. Keats
Publishing, Inc., 1985.
Barilla, J. et al. The nutrition superbook: volume 1: the antioxidants.
Keats Publishing, Inc., 1995.
Facino RM, et al. Free radical scavenging action and anti-enzyme activities
of procyanidines from Vitis vinifera. A mechanism for their capillary protective
action. Arzneimittelforschung, 44: 592-601, 1994.
Kuttan R, et al. Collagen treated with catechin becomes resistant to the
action of mammalian collagenase. Experientia, 37: 221-223, 1981.
Masquelier, J., et al. Stabilization du collagene par les oligomeres
procyanidoliques.
Acta Therapeutica, 7:101-105, 1981.
Masquelier, J. Aspects pharmacologiques nouveaux de certains
flavonoides.
A Vie Medical 12:1969.
Laparra, J., et al. Etude pharmaco-cinetique des oligomers procyandoliques
totaux du raisin. Acta Therapeutica, 4, 1978.
Laparra, J., et al. Etude pharmacocinetique des oligomeres
flavonoliques.
Plantes med et phyto, Tome XI, pp. 133-142, 1977.
Robert A.M.; Groult, N.; Six, C.; Robert, L. Etude de laction des
oligomeres procyanidoliques sur des cellules mesenchymateuses en culture.
Ii lattachment des fibres elastiques aux cellules. (Study of the effect
of procyanidolic oligomers on mesenchymal cells in culture. Ii attachment
of elastic fibers to the cells.) Pat Biol, (30)6:601-7, 1990.
Porter, Lawrence J., Wong Rosalind Y. Chan, Bock G. The molecular and crystal
structure of (+)-2,3-trans-3,4-trans-leucocyanidin [(2r,3s,+r)-(+)-3,3,
4.4, 5.7-Hexahydroxyflavan] dihydrate, and comparison of its
heterocyclic ring conformation in solution and the solid state. Journal
of the Chemical Society; Perkin Transactions I 1985. pp. 1413-17.
Masquelier, J. Proanthocyanidins et radicaux libres. 1985.
Uchida, S., et al. Condensed tannins scavenge active oxygen free radicals.
Med Sci Res, (15) 1987. pp. 831-832.
Ariga, T. Radical scavenging action and its mode in procyanidins b-1 and
b-3 from azuki beans to peroxyl radicals. Agric Biol Chem, 54(10) 1990.
pp. 2499-2504.
Da Silva, R., et. al. Radical scavenger capacity of different procyanidins
from grape seeds. Presented at a symposium, Free radicals in biotechnology
and medicine. Royal Society Of Chemistry, London January 1990, pp.
79-80.
Bauman, J., Wurm, G., Bruchhausen, F. Hemmung der prostagladinsynthetase
durch flavonoide und phenolderivate im vergleich nit deren 02 radikalfangereigenschaften
Arch Pharm, (Weinheim) 313 (1980) pp. 330-337.
Lombard, J., et al. The brain wellness plan. Kensington Pub. Corp., 1998.
Braverman, E., et al. The healing nutrients within: in facts, findings and
new research. Keats, 1987.
Facino, R.M., et al. Free radical scavenging action and anti-enzyme activities
of procyanidines from vitis vinifera. A mechanism for their capillary protective
action. Arzneimittelforschung, 44: 592-601, 1994.
Kuttan, R., Donnelly, P.V., Di Ferrante, N. Collagen treated with catechin
becomes resistant to the action of mammalian collagenase. Experientia, 37:
221-223, 1981.
Masquelier, J. Procyanidolic oligomers. J Parums Cosm
Arom, 95: 89-97, 1990.
Tixier, J.M., et al. Evidence by in vivo and in vitro studies that binding
of pycnogenols to elastin affects its rate of degradation by elastases.
Biochem Pharmacol, 33: 3933-3939, 1984.
Kakegawa, H., et al. Chem. Pharm. Bull. 33:5079, 1985.
Harmand, M.F., Blanquet, P. The fate of total flavanolic oligomers extracted
from vitus vinifera l. in the rat. European Journal of Drug
Metabolism and Pharmaccokinetics. 1978, No. 1 pp. 15-30.
Delrieu, P., Ding J., Escande, B., Samain, D. Free-radical scavenging activity
of proanthocyanidolic oligomers encapsulated in glycospheres: an in vivo
and in vitro study. Cosmetology Department & S Biovectors, Ramonville
St. Agne France. pp. 1-9.
Meunier, M.T., Villie, F., et al. Inhibition of angiotensin i converting
enzyme by flavanolic compounds: in vitro and in vivo studies. Planta
Medica,
May 26, 1986. pp. 12-15.
Barbier, A., et al. Activite angioprotectrice des oligomeres procyanidolques
chez lanimal-oedenme de la patte. Sanofi Res Toul Cedex Fr, pp31-40.
Barbier, A., et al. Activite angioprotectrice des oligomeres procyanidolques
chez lanimal-activite aniagoniste vis-a-vis des mediateurs de linflamation.
Sanofi Res Toul Cedex Fr, pp. 31-40.
Dubos, C., Durst, G., Hugonot, H. Evolution de la resistance
capillaire,
spontanement ou artificiellement diminuee par laction dune substance
capillaro-toxique chez des personnes agees--action benefique dun agnet
actif sur la micro-circulation: lEndotelon. Inform. Therapeut. 1980.
pp. 302-305.
Dartenuc, J.Y., et al. Resistance capillaire en geriatrie etude dun
microangioprotecteur-Endotelon. Bordeaux Med. 13:903-7, 1990.
Lagrue, G., Olivier-Martin, F., Grillot, A. Etude des effets des oligomeres
du procyanidol sur las resistance capillaire dand lhypertension arterielle
et certaines nephropathies. Sen. Hosp. Paris 18-25 Septembre, 1981.
Beylot, C., Bioulac, P. Essai therapeutique dun angioprotecteur
peripherique,
lEndotelon. Actualite Therapeutique Gaz. Med. de France (87)22:2919-24,
1980.
Lesbre, F.X., Tigaud, J.D. Effect de lEndotelon sur lindice
de fragilite capillaire dan une population specifique: les sujets
cirrhotiques. Gaz. Med. de France, (90)24 1983.
Sarrat, L. Abord therapeutique des troubles fonctionnels des membres inferieurs
par un microangioprotecteur lEndotelon. Bordeaux Med, 11:685-8, 1981.
Delacroix, P. Etude en double aveugle de lEndotelon dans linsuffisance
veineuse chronique. Therapeutique, la Revue de Medicine, (27-28) Sept. 1981.
pp. 1793-1802.
Thebaut, J.F, Thebaut, P., Vin, F. Etude de lEndotelon dand les manifestations
fonctionnelles de linsuffisance veineuse peripherique-resultats dune
etude en double aveugle portant sur 92 patients. Gazette Medicale,
(92)1, 1985. pp. 96-100.
Wegrowski, J., Robert, A.M., Maczar, M. The effect of procyanidolic oligomers
on the composition of normal and hypercholesterolemic rabbit aortas.
Biochem. Pharmacol, (33)21. 1984. pp. 3491-3497.
Chang, W.C., Hsu, F.L. Inhibition of platelet aggregation and arachidonate
metabolism in platelets by procyanidins. Prostagland Leukotri Essent Fatty
Acids, 38:181-8, 1989.
Masquelier, J. Pycnogenols: recent advances in the therapeutical activity
of procyanidins. Supplement of Planta Medica, Journal of Medicinal Plant
Research and Journal of Natural Products, July 1980 pp. 243-256.
Henning, B., et al. Lipid peroxidation and endothelial cell injury: implications
in atherosclerosis. Free Rad Path & Med, (4)1988 pp. 99-106.
Masquelier, J. Les procyanidols du vin leur role dans lalcoolisme.
pp. 88-93.
Gazave, J.M. Notions recentes sur les capillaires
unpub. bulletin
from the Laboratoire De Physiologie Patholigie pp. 26-29.
Ruf, J.C. Wine and polyphenols related to platelet aggregation and
atherothrombosis.
Office International Vigne et du Vin, Nutrition and Health Unit, Paris France;
Drugs under Experimental and Clinical Research (Switz.) 25/2-3 (125-131),
1999.
Blaszo, G. Gabor, M. Oedema-inhibiting effect of
procyanidin. Acta Physiologica
Academiae Scientiarum Hungaricae, Tomus 56(2):235-240, 1980.
Tayau, M.F, LeFevre, G. Action du leucocyanidol sur lhyalaluronidase.
Bull Soc Pharm Bordeaux, 95:132-136, 1956.
Lamy, M. Utilization des oligomeres procyanidoliques en
gynecologie. Essai
Therapeutique Tomel (14) Sept. 2, 1981. pp. 1021-22.
Henriet, J.P Une Etude Exemplaire Pour Un
Phlebotrope: letude EIVE. Unpub., pp. 77-83.
Pfister, A., Simon, M.T., Gazave, J.M. Sites de fixation des oligomeres
procyanidoliques dans la paroi des capillaires sanguins du poumon decobaye.
Acta Therapeutica (8) 1982. pp. 223-237.
Kuttan, R., Donnelly, P., Di Ferrante, N. Collagen treated with (+)
-catechin becomes resistant to the action of mammalian
collagenase.
Laboratory of Connective Tissue Research, Dept. of Biochem. Baylor Col.
of Med., Houston TX. 28, May, 1980.
Gendre, P., Laparra, J., Barraud, E. Effect protecteur des oligomeres
procyanidoliques sur le lathyrisme experimental chez le rat. Ann.
Pharm. Francaises, (43)1, 1985 pp. 61-73.
Corbe, C., Boissin, J.P., Siou, A. Light vision and chorioretinal circulation.
Study of the effect of procyanidolic oligomer (Endotelon). Jn. Fr.
Opthalmol,
(11)5:453-460, 1988.
Boissin, J.P., Corbe C., Siou, A. Chorioretinal circulation and dazzling:
use of procyanidol oligomers (Endotelon). Bull Soc Ophtalmol Fr, 88(2):173-4,
177-9, 1988.
Proto, F. et al. Electrophysical study of vitis vinifera procyanoside oligomers
effects on retinal function in myopic subjects. Ann Ott Clin Ocul, 114:85-93,
1988.
Saracco, J.B., Estachy, G.M. Etude d lEndotelon en
opthalmologie.
Gaz Med de France, 88:2035-2038, 1981.
Scharrer, A., Ober, M. Anthocyanosides in the treatment of retinopathies.
Klin Monatsbl Augenheilkd, 178:386-389, 1981.
Corbe, C., et al. Microangiopathy of the retina. J. Fr.
Opthalmol, 11:453,
1988.
Verin, M.M., Vildy, A., Maurin, J.F., Retinopathies et
O.P.C. Bordeaux Medicale,
(16)11. pp. 1467-74, 1978.
Soyeux, A. et al. Endotelon. Diabetic retinopathy and
hemorheology. Bull
Soc Ophtalmol Fr. 87(12):1441-4, 1987.
Fromantin, M. Les oligomeres procyanidoliques dans le traitement de
la fragilite capillaire et de la retinopathie chez les diabetiques. A propos
de 26 cas. Med Int, 16(11):432-434, Nov. 1981.
Arne, J.L. Contribution a letude des oligomeres procyanidoliques:
Endotelon, dans la retinopathie diabetique (a propos de 30 observations).
Gaz. Med. de France, Vol. 89, No. 30, Oct. 8, 1982.
Baruch, J. Effect of Endotelon in postoperative edema. Results of a double-blind
study versus placebo in 32 female patients. Ann Chir Plast Esthet 29(4):393-5,
1984.
Rao, C.N. et al. Influence of bioflavonoids on the collagen metabolism in
rats with adjuvantinduced arthritis. Ital J Biochem. 30:54-62, 1981.
Gabor, M. Pharmacologic effects of flavonoids on blood vessels.
Angiologica,
9:355-374, 1972.
Havsteen, B. Flavonoids, a class of natural products of high pharmacological
potency. Biochem Pharmacol, 32:1141-48, 1983.
Reimann, H.J., Lorenz, W., Fischer, M., Frölich, R., Meyer, H.J. Berkhauser
Verlag, Vol. 7/1, Univ. of Marburg/Lahn, Ger., 1977.
Masquelier, J. Action protectrice du vin sur lulcere
gastrique. Resultats,
p. 61.
Amella, M., et al. Inhibition of mast cell histamine release by flavonoids
and bioflavonoids. Planta Medica, 5116-20, 1985.
Packer, L., et al. The antioxidant miracle: your complete plan. John Wiley
& Sons, Inc., 1999.
Shaw, R. How [Australian] PycnoGenol [MASQUELIERs®] Helps Sports
People.
Masquelier, J. Procyanidolic oligomers
(leucocyanidins). Parfums Cosmet
Arom 95:89-97, 1990.
Pecking, A., Desprez-Curely, J.P., Megret, G. Oligomers procyanidoliques (Endotelon) dans le traitement des lymphoedemes
post-therepeutiques de members
superieurs. Symposium Satellite, Congres International dAngiologie,
Toulouse, France, 4-7 Oct. 1989.
Fahey, T.D., Pearl M. Hormonal effects of phosphatidylserine during 2 weeks
of intense training. Abstract submitted to national meeting of the Amer
College of Sports Medicine, June 1998.
Monteleone, P., Maj, M., Beinat, L.,
Natale, M., Kemali, D. Blunting by
chronic phosphatidylserine administration of the stress-induced activation
of the hypothalamo-pituitary-adrenal axis in healthy men. Eur J Clin Pharm
43: 385388, 1992.
Fahey, T.D., et al. The hormonal and perceptive effects of phosphatidylserine
administration during two weeks of resistive exercise-induced overtraining.
Bio of Sport 15(3):135-44, 1998.
Laparra, J., Michaud, J. Masquelier, J. Action des oligomeres procyanidoliques
sur le cobaye carence en vitamin c. Tavaux Originaux, University of Bordeaux,
1976.
Masquelier, J. Action comparee de divers facteurs vitaminiques p sur loxydation
de lacide ascorbique par les ions cuivriques. Bull. de la Societe
de Chimie Biologique XXXIII (3-4) 1951. pp. 302-304.
Masquelier, J. Action comparee de divers facteurs vitaminiques p sur lacide
ascorbique-oxydase. Bull. de la Societe de Chimie Biologique XXXIII (3,4)
1951. pp.304-306
Kakegawa, H., Matsumoto, H., Endo, K., Satoh, T.,
Nonaka, G., Mishioka,
I. Inhibitory effects of tannins on hyaluronidase activation and on
the degranulation from rat mesentery mast cells. Chem. Pharm. Bull.
33(11)1985. 5079-5082.
Reiman, H.J., Lorenz, M., Fischer, R.,
Frolich, H., Meyer, J. Histamine
and acute haemorrhagic lesions in rat gastric mucosa: prevention of stress
ulcer formulation by (+)-catechin, an inhibitor of specific histidine decarboxylase
in vitro. Dirkhauser Verlag,Vol. 7/1, 1977.
Pariente, J.J. Parientl-Amsellem, J. Les oedemes
post-traumatoqies
chez le sportif: essai controle de lEndothelon. Actualite Therapeutique
90(3) 2/11 1983 pp. 231-235.
Masquelier, J., et al. Flavonoids et Pycnogenols Int J Vit Nut
Res, (49)3:307-311, 1979.
Yu, C. L. et al. Mutagenicity of proanthocyanidins. Food Chem. Toxicol.
25(2):135-9, 1987.
Pantaleoni, G.C., Quaglino, D. Univerisity of Aquila Pharmacol-Toxicologica
Report, 1971.
Laparra, J., et al., Acta Therapeutica, 4:233, 1978.
Volkner, Wolfgang Muller, Ewald, Micronucleus assay in bone marrow cells
of the mouse with Pycnogenol. Cytotest Cell Research GmbH & Co., projects
143010 & 143021; Feb. 1989.
Acute and chronic toxicity tests. International Bio-Research, Inc., Hanover,
Germany, 1967-1971.
Dumon, M., Michaud, J., Masquelier, J. Proanthocyanidin content in vegetable
extracts to be used in the preparation of medicines. Bull. Soc. Pharm. Bordeaux,
129:51-65, 1990. |
|